Knowledge of CYP2C9 and VKORC1 genotype can improve dosing of warfarin.

被引：0
|
作者：
Kim, M.
Huang, S.
Frueh, F.
Rahman, A.
Burckart, G. J.
Thummel, K. E.
Lesko, L. J.
机构：
[1] Univ So Calif, US FDA, Silver Spring, MD USA
[2] Washington Univ, US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [41] Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes
    Wen, Ming-Shien
    Lee, M. T. Michael
    Chen, Jin-Jer
    Chuang, Hui-Ping
    Lu, Liang-Suei
    Chen, Chien-Hsiun
    Lee, Tsong-Hai
    Kuo, Chi-Tai
    Sun, Feng-Mei
    Chang, Yeu-Jhy
    Kuan, Pei-Liang
    Chen, Ying-Fu
    Charng, Min-Ji
    Ray, Chin-Ying
    Wu, Jer-Yuan
    Chen, Yuan-Tsong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 50 - 50
  • [42] Correction to: The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians
    Ahmed M. L. Bedewy
    Salah A. Sheweita
    Mostafa Hasan Mostafa
    Lamia Saeed Kandil
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 337 - 337
  • [43] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Taisei Mushiroda
    Yozo Ohnishi
    Susumu Saito
    Atsushi Takahashi
    Yuka Kikuchi
    Shigeru Saito
    Hideki Shimomura
    Yasuhiko Wanibuchi
    Takao Suzuki
    Naoyuki Kamatani
    Yusuke Nakamura
    Journal of Human Genetics, 2006, 51 : 249 - 253
  • [44] Combining genetic variations in CYP2C9 and VKORC1 with clinical factors for warfarin dosing determination improved clinical effectiveness
    Hong, Huixiao
    Jawaid, Ansar
    Wang, Jian
    Catalano, Jennifer
    Fox, Jayne C.
    Hawkins, Troy B.
    PHARMACOGENOMICS, 2013, 14 (05) : 459 - 460
  • [45] Polymorphism of the CYP2C9 and VKORC1 genes: a comment
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JORNAL VASCULAR BRASILEIRO, 2021, 20
  • [46] The Contribution of VKORC1 and CYP2C9 Genetic Polymorphisms and Patients' Demographic Characteristics with Warfarin Maintenance Doses: A Suggested Warfarin Dosing Algorithm
    Khaleqsefat, Esmat
    Khalaj-Kondori, Mohammad
    Bonyadi, Mortaza Jabarpour
    Soraya, Hamid
    Askari, Behnam
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (03): : 77 - 85
  • [47] Pharmacogenomics testing in a clinical laboratory: Technical and interpretation challenges in implementing VKORC1/CYP2C9 testing for warfarin dosing
    Langley, M.
    Booker, J.
    McLeod, H. L.
    Santos, C.
    Lange, L.
    Weck, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 660 - 661
  • [48] The accuracy of warfarin dosage based on VKORC1 and CYP2C9 phenotypes in a Chinese population
    Wijaya, Agustinus
    Bo, Jiang T.
    Jun, He
    Ping, Jiang W.
    Bin, Jiang
    Jie, Chen H.
    Wen, Yang B.
    Zhu, Xu M.
    Cheng, Qiu Q.
    MEDICAL JOURNAL OF INDONESIA, 2012, 21 (02) : 108 - 112
  • [49] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Mushiroda, T
    Ohnishi, Y
    Saito, S
    Takahashi, A
    Kikuchi, Y
    Saito, S
    Shimomura, H
    Wanibuchi, Y
    Suzuki, T
    Kamatani, N
    Nakamura, Y
    JOURNAL OF HUMAN GENETICS, 2006, 51 (03) : 249 - 253
  • [50] Frequency of CYP2C9 and VKORC1 Polymorphisms Affecting Warfarin Metabolism in an Indian Population
    Das, B.
    Chheda, P.
    Khadapkar, R. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 625 - 625
12345